Blog - Page 1102 of 5757

FridayMar 04, 2022 9:15 am

SRAX Inc. (NASDAQ: SRAX) Foresee Surging Revenue as Millennials are All-In on Corporate Transparency

SaaS company SRAX offers a robust suite of cutting-edge products that facilitate engagement between public companies and investors, both existing and potential SRAX forecasts a record first quarter of $11.5 million in revenue as part of 2022 revenue in the range of $46-$48 million The company bought back ~$800,000 during Q2 2021, paid a dividend in January, and optimized its cap table via the elimination of an ATM filing There are common fundamental threads between investing 30 years ago and today, but many things are extremely different. The digital age has changed everything, and fintech companies like SRAX (NASDAQ: SRAX)…

FridayMar 04, 2022 9:15 am

Studies Advance Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology for Significantly Improving Pharmaceutical Drugs

Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective use The company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies of its potential for treating high blood pressure and heart disease, nicotine addiction, and virus infection Most recently, the company reported successes in increasing the speed and effectiveness in a drug treating erectile dysfunction (“ED”) in laboratory animals Lexaria is preparing an investigational new drug (“IND”) application for its hypertension line of study with the aim of achieving a new drug application (“NDA”) approval from…

FridayMar 04, 2022 9:00 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Adds Indonesia Node as Lightning Network Reaches All-Time High

Bitcoin locked on the Lightning Network has an estimated value of US$1.3 billion – indicating a bullish market contrary to the Bitcoin bear market LQwD has nodes active on the Lightning Network in the U.S., Germany, Singapore, and Indonesia, growing at an exponential rate by the day The Bitcoin Payment Ecosystem is expected to reach US$880 million by 2026 LQwD launched its PaaS offering in November, aiming to facilitate payments worldwide Bitcoin reached an all-time high of US$61,374.28 in October 2021, but since then the cryptocurrency’s value fluctuated significantly, dropping to US$37,928.58 in January 2022 (https://ibn.fm/OMawU). Throughout February, Bitcoin value…

ThursdayMar 03, 2022 3:31 pm

QualityStocksNewsBreaks – Hollywall Entertainment Inc. (HWAL) on Path to Redefining Entertainment Space, Stamping Leading Position in Other Sectors

Hollywall Entertainment (OTC: HWAL) has become one of the most promising enterprises in the telecommunication, infrastructure, media, technology, entertainment, and broadcasting space. “With a background of years of developing, producing and acquiring some of the world’s most prized entertainment properties and brands, this company is well on its way to redefining the entertainment space and stamping its position as an industry leader in other sectors as well,” reads a recent article. Hollywall has several subsidiaries covering various sectors. “Its subsidiary, Hollywall Development Company (‘HWDC’), for instance, focuses on building, restoring, and creating ‘smart’ cities and communities, leveraging on broadband and…

ThursdayMar 03, 2022 2:58 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market

InMed Pharmaceuticals (NASDAQ: INM) is uniquely positioned to leverage the growing worldwide awareness of the potential of cannabinoids and the rising demand for rare cannabinoids. The company has begun this year on a high, following the 2021 acquisition of BayMedica and the launch of cannabicitran (“CBT”) sales. “With the launch of business-to-business sales of CBT in the health and wellness sector, InMed has further expanded its portfolio and its presence in the growing rare cannabinoid market,” reports a recent article. “CBT is the first of several new products InMed is planning to launch in the first half of 2022 in…

ThursdayMar 03, 2022 2:40 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Faster, Higher Overall Delivery of Sildenafil into Bloodstream

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released positive results from an animal study that evaluated DehydraTECH(TM) processing of the phosphodiesterase inhibitor (“PDE5 inhibitor”) sildenafil as potential use in the management of erectile dysfunction. “A clear trend emerged during the course of the study – a faster and higher overall delivery of sildenafil into the bloodstream. During the animal study, it was determined that in as little as four minutes of dosing, the DehydraTECH formulation of sildenafil delivered 74% more of the PDE5 inhibitor into the bloodstream on average than the concentration-matched, generic control formulation. Within seven minutes, the DehydraTECH-sildenafil formulation…

ThursdayMar 03, 2022 2:28 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Enters ACH Payment Processing Vertical, Opening Profitable Multimillion Revenue Stream

GreenBox (NASDAQ: GBOX), an innovative blockchain ledger fintech company, recently announced it would offer Automated Clearing House (“ACH”) processing capabilities to merchants leveraging its blockchain technology and smart contract technology to transfer funds electronically for ACH debit and credit transactions. ACH is a network payment system that handles credit transfers such as social security benefits, direct deposit of paychecks, dividend payouts, and tax refunds, as well as debit transfers such as subscription and mortgage payments and utility bills. It boasts low execution costs, making ACH payments an attractive and advantageous payment alternative for merchants by offering substantial cost savings to…

ThursdayMar 03, 2022 1:36 pm

QualityStocksNewsBreaks – Knightscope Inc.’s (NASDAQ: KSCP) K5 ASR to Boost Security Presence for New Texas-Based Client

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced that a Texas-based manufacturer of premium quality lubricants and associated products for the automotive, industrial and drilling markets will soon be welcoming a new K5 Autonomous Security Robot (“ASR”) to town. The announcement reads, “This family and minority owned business became dissatisfied with the unreliable and expensive security guards at its facility and was looking for an alternative to protect its property and deter unwanted visitors and criminals. The K5 ASR will provide a reliable, persistent presence needed to boost confidence in…

ThursdayMar 03, 2022 1:13 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Launches Same-Day Delivery in Chicago, Plainfield Areas

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has announced that it will be offering same-day delivery for its products across Chicago and Plainfield, IL. The company noted that this new offering is possible because of the company's acquisition of Peter Rubi LLC, which included the Peter Rubi brick-and-mortar locations in Chicago and Plainfield. The company will be using third-party delivery apps. According to the announcement, the addition of same-day delivery allows PlantX to deploy its ecommerce marketing expertise to these new retail locations. The company anticipates this new service as a way to increase its customer base through retail locations, as well as giving customers more…

ThursdayMar 03, 2022 12:36 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 2021 Financial Results, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today reported its financial results for the year ended Dec. 31, 2021. The company also provided a clinical update of its anti-cancer drug candidates currently in development for the treatment of primary and metastatic brain and CNS cancer. “Operationally 2021 was a terrific year for the company as we established the global framework for building and expanding our potentially pivotal clinical study of Berubicin for the treatment of GBM. Our priority remains focused…

Site Search

Company Search